Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle

Biology of Reproduction

Volumn 59, Issue 3, 1998, Pages 661-669

  Raga, Francisco ^a,b,c   Casañ, Eva Maria ^b,c   Kruessel, Jan S ^b   Wen, Yan ^b   Huang, Hong Yuan ^b   Nezhat, Camran ^b   Polan, Mary Lake ^b  

^a Stanford Univ School of Medicine ^*  (Spain)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; GONADORELIN; GONADORELIN RECEPTOR; MESSENGER RNA; PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031828974     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod59.3.661     Document Type: Article

References (60)

1. Schally AV, Arimura A, Kastin A, Matsuo H, Baba Y, Redding TW, Nair RM, Debeljuk L, White WF. Gonadotropin releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science 1971; 173:1036-1038.
2. Amoss M, Burgus R, Blackwell R, Vale W, Fellows R, Guillemin R. Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor of ovine origin. Biochem Biophys Res Commun 1971; 44:205-210.
3. Conn PM, Crowley WF Jr. Gonadotropin releasing hormone and its analogues. N Engl J Med 1991; 324:93-103.
4. Gibbons JM Jr, Mitnick M, Chieffo V. In vitro biosynthesis of THS and LH releasing factors by the human placenta. Am J Obstet Gynecol 1975; 121:127-131.
5. Khodr GS, Siler-Khodr TM. Placental LRF and its synthesis. Science 1980; 207:315-317.
6. Imai A, Furui T, Tamaya T. Is extrapituitary action of gonadotropin releasing hormone biologically significant?. Ann Clin Biochem 1992; 29:477-480.
7. Hsueh AJW, Jones PBC. Extrapituitary actions of gonadotropin releasing hormone. Endocr Rev 1981; 2:437-455.
8. Lee JN, Seppala M, Chard T. Characterization of placental luteinizing hormone releasing factor-like material. Acta Endocrinol 1981; 96: 394-397.
9. Eidne KA, Flanagan CA, Harris NS, Millar RP. Gonadotropin releasing hormone (GnRH) binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J Clin Endocrinol Metab 1987; 64:425-432.
10. Minaretzis D, Jakubowski M, Mortola JF, Pavlou SP. Gonadotropin releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. J Clin Endocrinol Metab 1995; 80:430-434.
11. Lin LS, Roberts VJ, Yen SS. Expression of human gonadotropin releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. J Clin Endocrinol Metab 1995; 80:580-585.
12. Wiznitzer A, Marbach M, Hazum Em Insler V, Sharoni Y, Levy J. Gonadotropin releasing hormone specific binding sites in uterine leiomyomata. Biochem Biophys Res Commun 1988; 152:1326-1331.
13. Chegini N, Rong H, Dou Q, Kipersztok S, Williams RS. Gonadotropin releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro. J Clin Endocrinol Metab 1996; 81:3215-3221.
14. Gorden JD, Polan ML. The use of GnRH agonist in breast and gynecological cancers. Semin Reprod Endocrinol 1993; 11:187-194.
15. Pahwa GS, Kullander S, Vollmer G, Oberheuser F, Knuppen R, Emons G. Specific low affinity binding sites for gonadotropin releasing hormone in human endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol 1991; 41:135-142.
16. Srkalovic G, Wittliff JL, Schally AV. Detection and partial characterization of receptor for [D-Trip6]-luteinizing hormone releasing hormone and epidermal growth factor in human endometrial carcinoma. Cancer Res 1990; 50:1841-1846.
17. Emons G, Schroder B, Ortmann O, Westphalen S, Schulz K, Schally AV. High affinity binding and direct antiproliferative effects of luteinizing hormone releasing hormone analogs in human endometrial cancer lines. J Clin Endocrinol Metab 1993; 77:1458-1464.
18. Imai A, Ohno T, Iida K, Fuseya T, Furui T, Tamaya T. Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types. Cancer 1994; 74:2555-2561.
19. Chatzaki E, Bax CM, Eidne KA, Anderson L, Grudzinskas JG, Gallagher CJ. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor. Cancer Res 1996; 56:2059-2065.
20. Pellicer A, Simon C, Miro F, Castellvi RM, Ruiz A, Ruiz M, Perez M, Bonilla-Musoles F. Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotropin-releasing hormone analogues in different phases of the menstrual cycle. Hum Reprod 1989; 4:285-289.
21. Pellicer A, Tarin JJ, Miró F, Sampaio M. De los Santos MJ, Remohi J. The use of gonadotropin releasing-hormone analogues (GnRHa), in in-vitro fertilization: some clinical and experimental investigations of a direct effect on the human ovary. Hum Reprod 1992; 7:39-47.
22. Emons G, Schally AV. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Hum Reprod 1994; 9:1364-1379.
23. Chegini N, Rong H, Dou Q, Kipersztok, Williams RS. Gonadotropinreleasing hormone (GnRH) receptor gene expression in human myometrium and leiomiomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro. J Clin Endocrinol Metab 1996; 81:3215-3222.
24. Wilshire GB, Emmi AM, Gagliardi CC, Weiss G. Gonadotropin-releasing hormone agonist administration in early human pregnancy is associated with normal outcomes. Fertil Steril 1993; 60:980-983.
25. Weissman A, Shoham Z. Favorable pregnancy outcome after administration of a long-acting gonadotropin-releasing hormone agonist in the mid-luteal phase. Hum Reprod 1993; 8:496-497.
26. Balasch J, Martinez F, Jové I, Cabré L, Coroleu B, Barri PN, Vanrell JA. Inadvertent gonadotrophin-releasing hormone agonist (GnRHa) administration in the luteal phase may improve fecundity in in-vitro fertilization patients. Hum Reprod 1993; 8:1148-1151.
27. Elefant E, Biour B, Blumberg-Tick J, Roux C, Thomas F. Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline. Fertil Steril 1993; 63:1111-1113.
28. Har-Toov J, Brenner SH, Jaffa A, Yavetz H, Peyser MR, Lessing JB. Pregnancy during long-term gonadotropin-releasing hormone agonist therapy associated with clinical pseudomenopause. Fertil Steril 1993; 59:446-447.
29. Young DC, Snabes MC, Poindexter AN. GnRH agonist exposure during the first trimester of pregnancy. Obstet Gynecol 1993; 81:587-589.
30. 6 LH-RH microcapsules during pregnancy: a case report. Hum Reprod 1990; 5:123-124.
31. Wilshire GB, Emmi AM, Gagliardi CC, Weiss G. Gonadotropin-releasing hormone agonist administration in early human pregnancy is associated with normal outcomes. Fertil Steril 1993; 60:980-983.
32. Ron-El R, Golan A, Herman A, Raziel A, Soffer Y, Caspi E. Midluteal gonadotropin-releasing hormone analog administration in early pregnancy. Fertil Steril 1990; 53:572-574.
33. Herman A, Ron-El R, Golan A, Nachum H, Soffer Y, Caspi E. Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long-acting agonist of gonadotrophin-releasing hormone. Hum Reprod 1992; 7:465-468.
34. Jackson AE, Curtis P, Amso N, Shaw RW. Exposure to LHRH agonists in early pregnancy following the commencement of mid-luteal buserelin for IVF stimulation. Hum Reprod 1992; 7:1222-1224.
35. Isherwood PJ, Ibrahim ZH, Matson PL, Morroll DR, Burslem RW, Lieberman BA. Endocrine changes in women conceiving during treatment with a LHRH agonist. Hum Reprod 1990; 5:409-412.
36. Gartner B, Moreno C, Marinaro A, Remohi J, Simon C, Pellicer A. Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilization cycle. Hum Reprod 1997; 2:2557-2559.
37. Smitz J, Camus M, Devroey P, Bollen N, Tournaye H, Van Steirteghem AC. The influence of inadvertent intranasal buserelin administration in early pregnancy. Hum Reprod 1991; 6:290-293.
38. Khodr GS, Siler-Khodr TM. Localization of luteinizing hormone-releasing factor (LRF) in the human placenta. Fertil Steril 1978; 29: 523-526.
39. Seppala M, Wahistrom T, Lehtovirta P, Lee JN, Leppaluoto J. Immunohistochemical demonstration of luteinizing hormone-releasing factor-like material in human syncytiotrophoblast, and trophoblastic tumors. Clin Endocrinol 1980; 12:441-451.
40. Siler-Khodr TM, Khodr GS. Luteinizing hormone releasing factor content of the human placenta. Am J Obstet Gynecol 1978; 130:216-219.
41. Prager D, Weber MM, Herman-Bonert V. Placental growth factors and releasing/inhibiting peptides. Semin Reprod Endocrinol 1992; 10:83-91.
42. Lin L, Roberts VJ, Yen S. Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. J Clin Endocrinol Metab 1995; 80:580-585.
43. Tsai SJ, Wiltbank MC. Quantification of mRNA using competitive RT-PCR with standard-curve methodology. Biotechniques 1996; 21: 862-866.
44. Krüssel JS, Huang HY, Simon C, Behr B, Pape AR, Wen Y, Bielfeld P, Polan ML. Single blastomeres within human preimplantation embryos express different amounts of messenger ribonucleic acid for β-actin and interleukin-1 receptor type I. J Clin Endocrinol Metab 1998; 83:953-959.
45. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1:3-25.
46. Simon C, Piquette GN, Frances A, Polan ML. Localization of interleukin-1 type I receptor and interleukin-1β in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab 1993; 77: 549-555.
47. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
48. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of human beta-actin cDNA. Nucleic Acids Res 1984; 12:1669-1687.
49. Adelman JP, Mason AJ, Hayflick JS, Seeburg PH. Isolation of the gene and hypothalamic cDNA for the common precursor of gonadotropin releasing hormone and prolactin release-inhibiting factor in human and rat. Proc Natl Acad Sci USA 1986; 83:179-183.
50. Chi L, Zhou W, Prikhozhan A, Flanagan C, Davidson JS, Golembo M, Illing N, Millar RP, Sealfon SC. Cloning and characterization of human GnRH receptor. Mol Cell Endocrinol 1993; 91:R1-R6.
51. Tazuke SI, Guidice LC. Growth factors and cytokines in endometrium, embryonic development, and maternal: embryonic interactions. Semin Reprod Endocrinol 1996; 14:231-243.
52. Ren SG, Braunstein GD. Human chorionic gonadotropin. Semin Reprod Endocrinol 1992; 10:95-105.
53. Petraglia F, Lim AT, Vale W. Adenosine 3′,5′-monophosphate, prostaglandins, and epinephrine stimulate the secretion of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. J Clin Endocrinol Metab 1987; 65:1020-1025.
54. Iwashita M, Kudo Y, Shinozaki Y, Takeda Y. Gonadotropin-releasing hormone increases serum human chorionic gonadotropin in pregnant women. Endocr J 1993; 40:539-544.
55. Siler-Khodr TM, Smikle CB, Sorem KA, Grayson MA, Spencer DK, Yoder BA, Khodr GS. Effect of excessive GnRH-binding substance on circulating maternal hCG in human pregnancy. Early Pregnancy 1997; 3:10-14.
56. Barnea ER, Kaplan M, Naor Z. Comparative stimulatory effect of gonadotropin releasing hormone (GnRH) and GnRH agonist upon pulsatile human chorionic gonadotropin secretion in superfused placental explants: reversible inhibition by a GnRH antagonist. Hum Reprod 1991; 6:1063-1069.
57. Pahwa GS, Kullander S, Vollmer G, Oberheuser F, Knuppen R, Emons G. Specific low affinity binding sites for gonadotropin-releasing hormone in human endometrial carcinomata. Eur J Obstet Gynecol Reprod Biol 1991; 41:135-142.
58. Seshagiri PB, Terasawa E, Hearn JP. The secretion of gonadotropin-releasing hormone by peri-implantation embryos of the rhesus monkey: comparison with the secretion of chorionic gonadotropin. Hum Reprod 1994; 9:1300-1307.
59. Kang IS, Kuehl TJ, Siler-Khodr TM. Effect of treatment with gonadotropin-releasing hormone analogues on pregnancy outcome in the baboon. Fertil Steril 1989; 52:846-853.
60. Skarin G, Nillius SJ, Wide L. Failure to induce early abortion by huge doses of a superactive LHRH agonist in women. Contraception 1982; 26:457-463.